Skip to content

Orphan Drugs: FDA February 2015 Approvals

March 12, 2015

 

 

 

 

The chart below identifies Orphan Drugs receiving FDA February 2015 approval as of 03/12/15 in ascending “Approval Date” order.

FDA February 2015 Orphan Products Receiving Approval

# Generic Name/Approval Date  Sponsor Company Indication
1 Lenvatinib (Lenvima)/ 02.13 Eisai Recurrent/metastatic/ progressive radioactive iodine refractory differentiated thyroid cancer
2 Panobinostat (Farydak)/ 02.23 Novartis Multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent

.

Please Note: “First Pigment Analysis (5893349712)” by NASA ICE (First Pigment Analysis Uploaded by russavia) [CC-BY-2.0] | Wikimedia Commons.

Copyright © 2012-2015, Orphan Druganaut Blog. All rights reserved.

 

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: